September 2016


Bio-Gate AG, a Mountain Partners portfolio company, announced break even. The company achieved a significant growth in the first half of 2016. The company’s revenue grew by almost 30 percent and EBITDA was positive.

Bio-Gate benefits from continuous high demand in the cosmetics business and in its strategic target markets; veterinary care, wound care, consumer and industrial business.

Bio-Gate, based in Nuremberg, is a leading medical technology company that develops antimicrobial products and multifunctional surfaces for medical technology. The company also refines cosmetics using micro silver (MicroSilver BG™) and equips nonmedical products with antimicrobial properties.

For the full year 2016, Bio-Gate forecasts strong revenue growth as well as positive EBITDA. This forecast is based on the positive business performance in the first half of 2016 and includes scheduled investments for new projects. Requirements for the forecast are that there are no major delays in the development projects and sales targets are met.

Comments are closed.